164 related articles for article (PubMed ID: 28620656)
1. Oxidative T Cell Modifications in Lupus and Sjogren's Syndrome.
Strickland FM; Mau T; O'Brien M; Ghosh A; Richardson BC; Yung R
Lupus (Los Angel); 2017 Apr; 2(1):. PubMed ID: 28620656
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of an epigenetically altered CD4(+) CD28(+) Kir(+) T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry.
Strickland FM; Patel D; Khanna D; Somers E; Robida AM; Pihalja M; Swartz R; Marder W; Richardson B
Lupus Sci Med; 2016; 3(1):e000147. PubMed ID: 27099767
[TBL] [Abstract][Full Text] [Related]
3. The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.
Alexander EL; McNicholl J; Watson RM; Bias W; Reichlin M; Provost TT
J Invest Dermatol; 1989 Dec; 93(6):751-6. PubMed ID: 2584740
[TBL] [Abstract][Full Text] [Related]
4. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency of CCR7
Wu C; Yang P; Liu H; Xiao W; Zhao L
Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636
[TBL] [Abstract][Full Text] [Related]
6. Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity.
Alunno A; Nocentini G; Bistoni O; Petrillo MG; Bartoloni Bocci E; Ronchetti S; Lo Vaglio E; Riccardi C; Gerli R
Reumatismo; 2012 Dec; 64(5):293-8. PubMed ID: 23256104
[TBL] [Abstract][Full Text] [Related]
7. The role of exercise in the rehabilitation of patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.
Strömbeck B; Jacobsson LT
Curr Opin Rheumatol; 2007 Mar; 19(2):197-203. PubMed ID: 17278938
[TBL] [Abstract][Full Text] [Related]
8. CD4(+) T cells epigenetically modified by oxidative stress cause lupus-like autoimmunity in mice.
Strickland FM; Li Y; Johnson K; Sun Z; Richardson BC
J Autoimmun; 2015 Aug; 62():75-80. PubMed ID: 26165613
[TBL] [Abstract][Full Text] [Related]
9. Sjögren's syndrome associated with systemic lupus erythematosus.
Taşdemir M; Hasan C; Ağbaş A; Kasapçopur Ö; Canpolat N; Sever L; Çalışkan S
Turk Pediatri Ars; 2016 Sep; 51(3):166-168. PubMed ID: 27738403
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
11. The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome.
Lauvsnes MB; Tjensvoll AB; Maroni SS; Kvivik I; Grimstad T; Greve OJ; Harboe E; Gøransson LG; Putterman C; Omdal R
Lupus; 2018 Nov; 27(13):2101-2111. PubMed ID: 30282561
[TBL] [Abstract][Full Text] [Related]
12. The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome.
Reveille JD
Curr Opin Rheumatol; 1992 Oct; 4(5):644-56. PubMed ID: 1419498
[TBL] [Abstract][Full Text] [Related]
13. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome.
Sawada S; Sugai S; Iijima S; Takei M; Paredes E; Hayama T; Nishinarita S; Hosokawa Y; Horie T; Obara T
Am J Med; 1992 Feb; 92(2):134-40. PubMed ID: 1543196
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
Gál I; Lakos G; Zeher M
Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
[TBL] [Abstract][Full Text] [Related]
15. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
16. Comparative Assessment of Hand Joint Ultrasound Findings in Symptomatic Patients with Systemic Lupus Erythematosus and Sjögren's Syndrome: A Pilot Study.
Lei L; Morgan S; Ntatsaki E; Ciurtin C
Ultrasound Med Biol; 2019 Feb; 45(2):452-460. PubMed ID: 30401509
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].
Ostuni P; Botsios C; Sfriso P; Bertagnin A; Cozzi F; Doria A; Todesco S
Minerva Med; 2002 Jun; 93(3):203-9. PubMed ID: 12094151
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase Cδ oxidation contributes to ERK inactivation in lupus T cells.
Gorelik GJ; Yarlagadda S; Patel DR; Richardson BC
Arthritis Rheum; 2012 Sep; 64(9):2964-74. PubMed ID: 22549474
[TBL] [Abstract][Full Text] [Related]
19. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
Hayashi Y; Haneji N; Hamano H; Yanagi K
Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
[TBL] [Abstract][Full Text] [Related]
20. The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome.
Reveille JD
Curr Opin Rheumatol; 1991 Oct; 3(5):722-30. PubMed ID: 1751307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
